RondinX
About RondinX
Founded in 2016 by leading microbiome experts, RondinX has built a cutting-edge microbiome technology platform set to unlock the potential of microbiome therapeutics. RondinX technology, including its PTR (Peak-to-Trough) family of algorithms, exclusively licensed from YEDA (the commercial arm of the Weizmann Institute of Science), is a proprietary, cloud-based, computational pipeline, integrating raw metagenomics, other omics and patient metadata to derive both static and dynamic strain level insights into the bacterial ecosystem.YEAR FOUNDED:
2016
LEADERSHIP:
CEO: Guy Harmelin
3 articles about RondinX
-
BiomX Acquires RondinX to Boost Microbiome Discovery and Development Capabilities
12/19/2017
The acquisition fortifies BiomX's bacterial target discovery capabilities and supports its product development pipeline.
-
RondinX Release: Company Expands Its Microbiome Computational Platform For Drug Development With A Unified Reference Range Of Bacterial Dynamics Based On Database Of 1,400 Healthy Individuals
1/23/2017
-
RondinX Release: Company Debuts To Accelerate Drug Development With A Breakthrough Microbiome Computational Platform
1/17/2017